BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2270695)

  • 1. Use of H2-receptor antagonists in children.
    Dimand RJ
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
    More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
    Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
    Moore JG
    DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of H2-receptor antagonists.
    Iberti TJ
    DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB; Friedman LS; Isselbacher KJ
    N Engl J Med; 1983 Dec; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract]   [Full Text] [Related]  

  • 7. Do H2 receptor antagonists have a therapeutic role in childhood?
    Kelly DA
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of stress ulcers with cimetidine and ranitidine. Comparative studies within the scope of cardiosurgical interventions].
    Duma S
    Wien Med Wochenschr; 1986 Sep; 136(18):467-72. PubMed ID: 3798932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine versus antacids in the prevention of stress erosions in critically ill patients.
    Poleski MH; Spanier AH
    Am J Gastroenterol; 1986 Feb; 81(2):107-11. PubMed ID: 3946364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dosage alternative for H2-receptor antagonists--constant infusion.
    Siepler JK
    Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ulcer disease.
    Spenney JG
    Ala J Med Sci; 1985 Jan; 22(1):49-53. PubMed ID: 3883827
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for peptic ulcer disease.
    Voirin J
    Am Fam Physician; 1984 Dec; 30(6):154-9. PubMed ID: 6095630
    [No Abstract]   [Full Text] [Related]  

  • 20. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.